EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
This article reports a clinical case of administration of canakinumab (Ilaris®), an interleukin-1β inhibitor, in a patient with chronic tophacaceous gout resistant to therapy with nonsteroidal anti-inflammatory drugs, glucocorticoids, and colchicine. The results show a good and long-term clinical ef...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA PRESS LLC
2014-03-01
|
| coleção: | Научно-практическая ревматология |
| Assuntos: | |
| Acesso em linha: | https://rsp.mediar-press.net/rsp/article/view/1365 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|